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INTRODUCTION
Research	 for	 new	 anticancer	 drugs	 is	 a	
very	 active	 domain,	 as	 long	 as	 natural	 products	
represent	 an	 important	 source	 of	 new	 drugs.	
Nowadays,	more	than	60%	of	the	new	therapeutic	
compounds	 are	 either	 isolated	 from	 natural	
products,	 or	 incorporate	 themselves	 synthetic	
compounds,	which	have	similar	chemical	structure	
of	 some	natural	 products	 (Chabner	 and	Roberts,	
2005).
Plants	from	the	Celastraceae	family	have	been	
used	for	centuries	in	traditional	medicine,	in	South	
America,	China,	and	Africa	(Descoins	et al.,	2002).	
Of	 all,	 Euonymus alatus (Thunb) Celastraceae 
(EA),	 a	 species	 native	 to	 Southeastern	 Asia,	 is	
commonly	 recommended	 as	 medicinal	 plant,	
inclusive	in	cancer	treatment	(Xu,	2015).		Various	
authors	 described	 several	 pathways	 responsible	
for	 its	 remarkable	 anticancer	 properties;	 two	 of	
them	 are	 of	main	 importance.	 According	 to	 Kim	
et al.	 (2006),	 it	 exhibits	 antitumor	properties	by	
inducing	 apoptosis	 via	 mitochondrial	 pathway.	
Other	 authors	 showed	 that	 EA	 inhibits	 tumor	
invasion,	 mainly	 by	 suppression	 of	 the	 matrix	
metalloproteinase-9	 (MMP-9)	 activity	 (Cha	
et al.	 2003,	 Jin	 et al.	 2005),	 effect	 provided	 by	
dihydroxycinnamic	acid	(caffeic	acid)	(Park	et al.,	
2005).	The	inhibition	of	MMP-2	and	MMP-9	seems	
to	be	mediated	by	NK-kappaB	pathway	(Chung	et 
al.,	2004).	
Euonymus europaeus	 L.,	 (EE)	 known	 also	 as	
the	 spindle	 tree,	 is	 the	 only	 European	 represen-
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Abstract
Euonymus europaeus	L.	(EE),	is	the	only	European	representant	of	the	Celastraceae	family,	with	limited	use	in	
phytotherapy.	In	the	present	study,	we	investigated	the	anticancer	effects	of	EE	hydro	alcoholic	extract	prepared	
from	fresh	fruits.	HPLC	analysis	revealed	the	presence	of	evodiamine	in	concentration	of	0.404	g/ml.	Antitumor	
effect	was	assessed	in vivo on Swiss	mice.	Mice	implanted	with	transplantable	tumor	cells	were	treated	with	25	
or	50	mg/kg	EE	extract,	by	 IP	 injection	on	 the	1st,	3rd	 and	6th	day,	 the	study	 lasted	 for	14	days	 long.	A	parallel	
study	assesses	the	median	survival	rate.	EE	therapy,	at	the	higher	dose,	prevented	the	body	weight	gain	(p<0.001),	
reduced	 the	 volume	of	 ascitic	 fluid	by	71.88%	 (p	<	0.001)	 and	 increased	 the	median	 survival	 rate	by	28.57%	
(p<0.05).	
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tative	 of	 the	 Celastraceae	 family.	 It	 is	 a	 small	
deciduous	 tree	 with	 poisonous	 fruits,	 with	 very	
limited	 use	 in	 phytotherapy	 until	 now.	 	 Few	
phytochemical	analysis	performed	on	EE	revealed	
some	 active	 compounds	 including	 sesquiterpene	
polyesters	belonging	 to	 the	 alatol,	 3-deoxymatol,	
3,4-dideoxymaytol	 families,	 evonimate	 alkaloids,	
dihydro-ß-agarofuran	polyesters	 (Descoins	et al.,	
2002),	 and	 lectins	 (Teneberg	 et al.,	 2003)	 with	
erythrocyte	agglutination	properties	(Agostino	et 
al.	2015).
The	aim	of	the	present	study	is	to	investigate	
the	anticancer	activity	of	EE	alcoholic	extract	using	
a	transplantable	tumor	models	in vivo.	
MATERIALS AND METHODS
Plant materials and extraction
Fresh	 fruits	 of	 EE,	 harvested	 in	 September	
2011,	 from	 the	 forests	 near	 Cluj,	 Romania,	were	
used	 to	 prepare	 the	 hydro	 alcoholic	 extract.	 The	
collecting	 of	 fruits	 was	 performed	 according	
to	 the	GACP	 rules,	 from	an	unpolluted	 area,	 at	 a	
minimum	 of	 3	 km	 distance	 from	 any	 circulated	
roads.	 The	 fruits	 were	 identified	 by	 the	 Quality	
Control	laboratory	of	PlantExtrakt	TC	Ltd,	Rădaia,	
Cluj	 County,	 Romania.	 A	 voucher	 specimen	 was	
filed	 and	 kept	 in	 the	 company	 archives	 (B.	 no.	
063811,	CoA	4817/20.09.2011).	
The	moisture	 in	 the	 fresh	vegetal	material	 is	
70	%.,	as	described	in	previous	studies	(Sevastre	et 
al.,	2014).	Briefly,	the	freshly	cut	vegetal	material	
was	mixed	with	90	%	vol.	ethanol,	at	1:0.7	ratio.	
The	 mixture	 was	 kept	 at	 room	 temperature	 for	
ten	days	long,	and	then,	the	mixture	was	pressed	
and	filtered.	All	steps	were	performed	on	an	API-
GMP	certified	production	flow	at	SC	Plant	Extrakt	
SRL	 in	 Rădaia,	 Cluj	 County,	 Romania,	 according	
to	 method	 2a	 from	 the	 German	 Homoeopathic	
Pharmacopoeia.
Before	 use,	 the	 alcoholic	 solution	 was	 pro-
cessed	 in	 a	 rotary	 evaporator	 at	 40°C,	 until	 3/4	
of	the	content	was	evaporated,	 then	refilled	with	
sterile	 saline	 solution	 up	 to	 0.5ml/animal.	 The	
aqueous	 solution	 was	 sterilized	 by	 transferring	
throughout	 syringe	 filters,	 and	 was	 immediately	
administered.	 The	 control	 group	 received	 a	
placebo,	0.5ml	alcohol	70°,	previously	evaporated,	
similarly	to	the	plant	extract	method.	
Standardization of mother tincture
The	standardization	procedures	were	already	
presented	 in	 previous	 studies	 (Sevastre	 et al.,	
2014),	 however	 the	methods	 were	 being	 briefly	
described	in	the	paragraphs	below.	
Determination of aspect, relative density, 
dry residue and ethanol content
The	 countenance,	 color	 and	 smell	 of	mother	
tincture	 was	 determined	 by	 observation,	
additionally	 relative	density,	dry	 residue	and	 the	
ethanol	content	were	determined
Thin-layer chromatography (TLC)
The	 Thin-layer	 chromatography	 (TLC)	
determination	 was	 performed	 according	 to	 the	
German	 Homeopathic	 Pharmacopoeia.	 10	 ml	 of	
EE	extract	was	mixed	for	five	minutes	with	20	ml	
water	and	10	ml	9.5	%	lead	acetate.	The	extraction	
was	made	with	2	x	15	ml	mixture	of	 chloroform	
–	 iso-propanol	(3:2,	v/v).	The	organic	phase	was	
separated	 and	 dried	 at	 maximum	 50˚C.	 The	 dry	
residue	was	dissolved	in	0.5	ml	methanol.	40	µl	of	
prepared	sample	and	20	µl	of	standard	solutions,	
respectively,	were	applied	on	TLC	plate.	The	TLC	
determination	 was	 performed	 on	 Silicagel	 F254	
plates,	 using	 as	mobile	 phase	 a	mixture	 of	 ethyl	
acetate,	 methanol	 and	 water	 (81:11:8,	 v/v).	
Digitoxin	 0.5	 mg/ml	 and	 lanatosid	 C	 0.5	 mg/
ml,	 respectively,	 were	 used	 as	 standards.	 The	
evaluation	of	the	plate	was	made	after	spraying	it	
with	a	mixture	of	3	%	trichloramine	T	and	25	%	
trichloracetic	acid	(2:8,	v/v),	exposing	it	to	heating	
for	5-10	minutes,	at	105-110˚C	and	visualizing	 it	
afterwards	in	fluorescence	at	365	nm.
Determination of evodiamine content
The	 evodiamine	 content	was	 determined	 by	
HPLC,	using	a	method	provided	by	Phytolab	and	
adapted	in	the	view	of	getting	a	better	separation	
of	 compounds	 from	 mother	 tincture,	 as	 a	 start.	
The	determination	was	performed	using	a	Varian	
ProStar	 HPLC	 system.	 A	 Phenomenex	 Luna	 C18	
silicagel-C18	column	was	used,	150	mm	x	4.6	µm	
with	a	precolumn	of	5	mm	x	4.6	µm,	both	having	
particles	 of	 5	 µm.	 As	 a	 mobile	 phase,	 a	 solvent	
gradient	with	phosphoric	acid	pH=2.5,	water	and	
acetonitrile,	with	a	1	ml/min	flow	rate	were	used.	
The	detection	was	performed	with	a	DAD	detector	
at	228	nm.	The	UV-Vis	spectra	were	recorded	from	
200	nm	to	600	nm.
Volumes	 of	 100	 µl	 of	 EE	 extract	 from	 each	
concentration	 of	 standard	 evodiamine	 solution	
were	injected.	For	the	quantitative	determination,	
a	 calibration	 curve	 with	 concentrations	 of	
evodiamine	 ranging	 between	 50	 µg/ml	 and	 500	
µg/ml	was	built.	The	calibration	curve’s	equation	
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is	 A	 =	 60110xC	 –	 478977	 and	 the	 correlation	
factor	 is	 0.9807.	 The	 identification	 was	 made	
based	 on	 the	 comparison	 between	 the	 retention	
time	and	UV-Vis	spectra	of	compounds	separated	
from	EE	extract	and	the	standard	evodiamine.	The	
absorption	maximum	of	evodiamine	is	at	228	nm.
Animal care and experimental procedures
The	experiments	on	animals	were	performed	
according	 to	 the	 Directive	 2010/63/EU	 of	 the	
European	Parliament	and	of	the	Council	and	Low	
no.	 43/11.04.2014	 of	 the	 Romanian	 Parliament,	
following	the	guidelines	of	Guide for the Care and 
Use of Laboratory Animals	(Department	of	Health	
Education,	 and	 Welfare,	 National	 Institute	 of	
Health,	1996).	The	Bioethical	Board	of	the	Faculty	
of	 Veterinary	 Medicine,	 Cluj-Napoca,	 authorized	
the	 experiment.	 The	 animals	 were	 housed	 in	
polycarbonate	cages,	at	a	controlled	temperature	
(21-22ºC),	 humidity	 (40-60%)	 and	 12/12h	
light/dark	 cycle.	 Standard	 lab	 chow,	provided	by	
National	 Institute	 for	Research	and	Development	
Cantacuzino	 Bucharest,	 and	 water	 were	 freely	
available.	Albino	Swiss	female	mice	were	used	in	
these	 experiments,	 having	 a	 body	 weight	 about	
33.75±3.52	g.
In	 the	 present	 study,	 we	 performed	 two	 in-
dependent	experiments:	the	first	one	was	designed	
to	assess	the	antiproliferative	effect	of	the	extract	
and	the	ability	to	reduce	the	side	effect	of	tumor	
growth,	 while	 the	 second	 one	 was	 dedicated	 to	
survival	analysis.	
For	 the	 first	 experiment,	 the	 animals	 were	
organized	in	three	equal	groups	of	eight	mice,	and	
treated	as	follow:	
I.	-	mice	implanted	with	Ehrlich	ascites	carcinoma	
(EAC)	cells,	106	ascitic	cells	each,	on	day	0,	and	
placebo	intraperitoneally;	
II.	-	EAC	implanted	mice,	receiving	50	mg/kg	b.w.;	
EE	extract,	IP
III.	-	EAC	implanted	mice,	receiving	25	mg/kg	b.w	
EE	extract,.	IP;	
All	 animals	 received	 the	 EE	 ethanolic	 extract	 on	
the	 1st,	 3rd	 and	 6th	 day.	 The	 body	 weight	 was	
measured	on	a	daily	basis,	until	the	end	of	the	
study.	
Ehrlich ascitic fluid	was	implanted	(106	tumor	
cells/mouse), on	day	0	of	the	experiment.	Fourteen	
days	after	EAC	implantation,	blood	was	collected	
from	 the	 retro	 orbital	 sinus	 under	 anesthesia	
and	 the	 animal	 were	 subsequently	 euthanized.	
Complete	blood	count	(CBC)	was	performed	using	
Abacus	 Junior	 Vet,	 automatic	 analyzer	 (Diatron	
Messtechnik,	Budapest,	Hungary).	
The	volume	of	ascitic	fluid	was	measured	with	
a	 syringe,	 and	 then	 transferred	 in	 a	 phosphate	
buffer	solution	(4°C,	pH	7.4).	The	cell	viability	was	
assessed	 by	 Tripan	 blue	 staining	 (0.4%	 in	 PBS),	
the	total	and	viable	tumor	cell	concentration	was	
counted	by	using	a	hemocytometer	(dilution	1:10).	
Smears	 were	 made	 from	 peritoneal	 fluid	 and	
stained	 by	Dia Quick Panoptic method.	 The	 cells	
were	then	differentiated	on	a	100x	field	objective,	
by	 an	 observer	 unaware	 of	 the	 experimental	
design.	 The	 cells	 were	 differentiated	 into	 tumor	
cells,	 neutrophils,	 macrophages,	 lymphocytes	
using	 classic	 morphological	 patterns,	 counting	
200	 cells	 for	 each	 sample,	 based	 on	 classical	
morphological	criteria	(Jain,	1993).	
For	 the	 second	 experiment,	we	 use	 only	 the	
higher	 dose	 of	 E. europaeus	 (50mg/kg).	 Sixteen	
animals	were	organized	in	two	equal	groups:	both	
implanted	 with	 Ehrlich	 ascites	 carcinoma	 (EAC)	
cells,	 one	 group	 was	 treated	 and	 the	 other	 one	
not.	In	this	study	we	performed	two	experiments:	
one	in	which	the	animals	were	allowed	to	live	for	
2	weeks	 long	 and	 then	 euthanized	 to	 assess	 the	
amount	 of	 ascitic	 fluid	 and	 cellular	 content	 of	
ascitic	 fluid	(all	of	 them	survived	to	 the	end	of	2	
weeks),	and	 the	second	experiment	 in	which	 the	
animals	were	not	killed	but	observed	until	the	day	
they	die,	by	a	survival	test.	The	results	were	then	
analyzed	 by	 Long	 Rank	 test	 and	 survival	 curves	
were	generated.
Statistical analysis
All	 data	 are	 reported	 as	 the	 mean	 ±	 SEM.	
The	 Gaussian	 distribution	 was	 checked	 by	 the	
Shapiro-Wilk	normality	 test.	One-way	analysis	of	
variance	ANOVA,	 followed	by	post	hoc	Dunnett’s	
range	test	procedure	was	performed	for	pair-wise	
comparisons	between	 the	volume	of	 ascitic	 fluid	
and	variation	of	viable	cells	 concentration,	while	
the	 two-way	 ANOVA	 followed	 by	 the	 Bonferroni	
post-test	 was	 the	 choice	 for	 the	 variation	 of	
body	 weight.	 Pearson’s	 correlation	 was	 used	 in	
order	to	assess	the	correlation	between	normally	
distributed	 variables;	 this	 interpretation	 was	
made	 according	 to	 the	 Colton	 scale.	 Statistical	
significance	 was	 at	 p<0.05	 (95%	 confidence	
interval).	The	comparison	between	survival	curves	
was	evaluated	throughout	Long-rank	(Mantel-Cox)	
Test.	Statistical	values	and	figures	were	obtained	
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using	 GraphPad	 Prism	 version	 5.0	 for	Windows,	
GraphPad	Software,	San	Diego	California	USA.
RESULTS AND DISCUSSION
Standardization	of	the	studied	mother	tincture
The	obtained	hydro	alcoholic	extract	(mother	
tincture)	 was	 a	 clear,	 brown-orange	 liquid.	 The	
quality	 parameters	 of	 the	 extract	 were	 within	
the	 admissibility	 range	 of	 German	 Homeopathic	
Pharmacopoeia.	 TLC	 chromatogram	 of	 the	 EE	
extract	 showed	 the	 presence	 of	 lanatoside	 C,	 a	
cardiotonic	 glycoside.	 Hence,	 only	 insignificant	
amount	 of	 digitoxin	 was	 also	 found.	 HPLC	
chromatogram	 revealed	 the	 presence	 of	
evodiamine	in	concentration	of	0.404	g/ml,	while	
the	 recorded	 UV-vis	 spectra	 further	 proved	 the	
presence	of	evodiamine	in	the	extract	(Sevastre	et 
al.,	2014)
Antiproliferative effect in vivo
In	 EAC	 inoculated	 mice,	 the	 WBCs	 count	
was	four	times	over	the	normal	maximum	range.	
The	 blood	 leukocytosis	 was	 mainly	 based	 on	
neutrophilia	 (p<0.001),	 but	 the	 lymphocytes	
number	 was	 also	 significantly	 increased	
(p<0.001).	 A	 significant	 decrease	 in	WBCs	 count	
was	 observed	 in	 mice	 treated	 with	 EE	 alcoholic	
extract,	 both	neutrophils	 and	 lymphocytes	 being	
influenced	(Tab.	1.).	
The	blood	neutrophils	were	positively	corre-
lated	 with	 the	 lymphocytes	 (r=0.55,	 p<0.01),	
but	 not	 with	 other	 leucocytes.	 Neutrophils	 also	
showed	 a	 good	 positive	 correlation	 with	 fibrin	
content	 of	 the	 ascitic	 fluid	 (r=0.52,	 p<0.05)	 and	
congestion	of	the	abdominal	wall	(r=0.43,	p<0.05).	
There	was	also	a	positive	correlation	between	the	
number	 of	 neutrophils	 and	 the	medium	 platelet	
volume	 (r=0.63,	 p<0.01),	 which	 suggested	 a	
common	inflammatory	mechanism	beneath	these	
two	hematological	changes.	
The	body	weight,	as	a	measure	of	Ehrlich	ascites	
accumulation	in	the	peritoneal	cavity	is	shown	in	
figure	1.	As	expected,	the	ascites	development	was	
followed	 by	 32.90	 ±	 7.98%	 increase	 in	 the	 body	
weight.	 The	 EE	 therapy	 prevents	 body	 weight	
gain.	 The	 differences	 were	 visible	 starting	 from	
the	 third	day	of	 the	 study:	 both	doses	proved	 to	
provide	significant	protection,	but	 the	effect	was	
more	visible	in	the	group	treated	with	the	higher	
dose.
The	amount	of	ascitic	 fluid	varied	proportio-
nally	 with	 the	 body	 weight	 gain.	 50	 mg/kg	 EE	
administered	 reduced	 by	 71.88%	 the	 medium	
volume	of	ascites	fluid,	but	the	lower	dose	(25	mg/
kg)	was	also	effective;	it	reduced	the	accumulation	
of	ascitic	 fluid	by	up	to	39.06%	(EAC	10.67±2.42	
ml,	EAC+50	mg/kg	3.06±0.75	ml,	EAC+25	mg/kg	
6.50±1.44	ml,	p<0.05)	(Fig	2	A).	
The	 total	 viable	 tumor	 cell	 concentration	 in	
the	peritoneal	fluid	significantly	decreased	in	the	
groups	treated	with	EE.	The	extract	administered	
in	 dose	 of	 50	mg/kg	 and	 25	mg/kg	 reduced	 the	
tumor	 cell	 concentration	 by	 up	 to	 67.93%	 and	
66.30%	(p<0.01)	(Fig.	2	B).	
The	 correlation	 test	 showed	 a	 positive	
correlation	between	the	percentage	of	body	weight	
gain	and	the	amount	of	ascitic	fluid	(r=0.54	p<0.05),	
but	no	relation	between	the	amount	of	ascitic	fluid	
and	the	tumor	cell	concentration	could	be	proven	
(r=-0.044,	 p=0.89).	 Furthermore,	 the	 cellularity	
of	 the	ascitic	 fluid	was	positively	correlated	with	
the	blood	neutrophils	count	(r=0.803,	p<0.01),	but	
again,	no	correlation	with	the	ascitic	volume	could	
be	proven	(r=0.12,	p=0.72).	
The	evaluation	of	ascitic	hemorrhage	showed	
that	EE	therapy	provided	some	protection,	but	the	
semiquantitive	 analysis	 showed	 no	 statistically	
significant	 data.	 The	 hemorrhagic	 aspect	 of	 the	
ascitic	 fluid	 is	 due	 to	 extensive	 leaking	 of	 red	
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Tab. 1. The	 effect	 of	 E. europaeus alcoholic	 extract	 on	 the	 WBC	 count	 and	
differential		 count		 (mean	±	S.E.M.)	(109cells/L)
Group WBCs N E B L M 
I 46.79±2.05 31.72±2.82 0.30±0.14 0.07±0.06 12.81±1.96 1.88±0.34
II 11.59±2.40*** 6.04±1.39*** 1.00±0.68 0.01±0.01 2.84±0.43*** 1.69±0.59
III 19.58±2.39*** 12.73±1.53*** 0.31±0.09 0.06±0.04 5.19±0.68** 1.29±0.20
(**	=	p>0.01,	***	=	p>0.001	as	compared	to	EAC	group)
S.E.M	=	Standard	Error	of	the	Mean	(8	animals	/	group)
WBCs	–	White	blood	cells,	N	–	Neutrophils,	E	–	Eosinophils,	B	–	Basophiles,	L	–	Lymphocytes,	M	–	Monocytes		
Normal	values:	WBC	2.61-10.05	103cells/µl,	N	0.4-2.0	103cells/µl,	L	1.27-8.44	109/l,	M	0-0.29	103cells/µl,	E	0-0.17	
103cells/µl,	B	0-0.02	103cells/µl	(Jain,	1993)
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blood	 cells	 into	 the	 peritoneal	 cavity	 and	 it	 is	 a	
malignant	side	effect	of	EAC	development	(Mayer,	
1966).	Many	ascitic	samples	rich	in	red	blood	cells	
also	 showed	 a	 high	 fibrin	 content,	 probably	 also	
related	 to	 the	 increased	 vascular	 permeability	
in	 the	 abdominal	 wall	 capillaries.	 The	 vascular	
changes	of	 the	abdominal	wall	were	 less	evident	
in	groups	subjected	to	therapy,	but	the	differences	
were	not	statistically	sustained.
The	 percentage	 of	 white	 blood	 cells	 in	 the	
ascitic	fluid	was	several	times	higher	in	EE	treated	
mice,	while	the	tumor	cell	percentage	decreased.	
Neutrophils	 were	 the	 most	 prevalent	 category,	
but	 lymphocytes	were	also	 found	 (tab.	2).	These	
findings	 suggest	 that	 the	 inflammatory	 cells	 in	
the	ascitic	fluid	provided	some	protection	against	
ascites	 development,	 while	 blood	 leucocytes	 did	
not.	The	correlation	test	confirms	this	observation,	
while	 ascitic	 lymphocytes	 showed	 a	 negative	
correlation	with	fibrin	content	in	the	ascitic	fluid	
(r=-0.52,	p<0.05)	and	congestion	of	the	abdominal	
wall	 (r=0.51,	 p<0.05);	 neutrophils	 found	 in	 the	
ascitic	 fluid	were	also	negatively	 correlated	with	
these	two	parameters.
Blood	 neutrophilic	 leukocytosis	 is	 a	 side	
effect	 of	 tumor	 cell	 proliferation	 in	 response	 to	
tumor	 inflammatory	 cytokines	 (Liao	et al.,	 2005,	
Sarpataki et al.,	 2011),	 but	 the	 efficiency	 of	 this	
reactive	response	seems	to	be	limited	because	the	
circulating	inflammatory	cells	fail	to	pass	through	
capillary	 walls	 and	 migrate	 into	 the	 peritoneal	
fluid.	 Consequently,	 the	 ascitic	 fluid	 in	 control	
EAC	 implanted	 mice	 is	 rich	 in	 tumor	 cells,	 but	
the	 inflammatory	 cells	 are	 sparsely	 distributed.	
As	a	result	of	therapy,	the	number	of	tumor	cells	
decreased,	 but	 the	 percentage	 of	 inflammatory	
cells	 in	 the	 ascitic	 fluid	was	 elevated,	 in	 inverse	
correlation	with	the	circulating	blood	leukocytes.
The	EE	 anticancer	 effect	was	 further	proved	
within	 the	 survival	 experiment	 carried	 out.	 The	
therapy	increased	by	28.57%	the	median	survival	
of	EAC-bearing	mice	(EAC	median,	14	days,	EAC	+	
EE	50	mg/kg	b.w.,	18	days;	p<0.05)	(Fig	3).
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Fig. 1. Effects	of	Euonymus europaeus	extract	on	the	body	weight	gain	(g)	
(*	=	p>0.05:	**	=	p>0.01;	***	=	p>0.001	as	compared	to	EAC	group).
(mean	±	SEM)	(8	animals	/	group)
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Initially,	phytochemical	investigation	searched	
for	 phytotherapeutic	 compounds	 already	 known	
to	 be	 found	 in	 the	 EE	 extract,	 such	 as	 cardiac	
glycosides	as	digitoxin	and	lanatoside	c.	However,	
cardiac	 glucosides	 alone	 seems	 to	 be	 unable	 to	
explain	this	potent	anticancer	effect	on	their	own,	
thus,	 we	 searched	 for	 more	 compounds,	 and,	
eventually,	evodiamine	was	found.	
In vivo	 studies	 were	 performed	 on	 a	 classic	
transplantable	 tumor	 model	 –	 Ehrlich	 ascites	
carcinoma	 inoculated	 in	 mice.	 This	 study	
provided	 valuable	 information	 regarding	 the	
antiproliferative	 potential	 of	 the	 EE	 extract,	 but	
they	also	implied	important	limitations	related	to	
kinetics,	 bioavailability,	 tissue	 distribution,	 route	
of	systemic	circulation,	catabolism	and	secretion.	
Therefore,	we	consider	that	further	studies	need	to	
be	carried	out	in	order	to	establish	its	applicative	
value	in	finding	new	molecules	that	can	be	used	in	
cancer	therapy.	
Little	 is	 known	 about	 the	 pharmacological	
properties	 of	 E. europaeus,	 but	 several	 studies	
found	 various	 active	 compounds	 in	 this	 plant,	
some	of	them	with	possible	anticancer	effect,	like	
sesquiterpenes,	 alkaloids	 (Descoins	et al.,	 2002),	
lectins	(Teneberg	et al.,	2003).	On	the	other	hand,	
the	other	members	of	Euonymus	species	ex	E alatus 
have	well	 documented	 anticancer	 properties.	 An	
antiproliferative	 mechanism	 was	 proposed	 for	
mammary	 and	 genital	 tumors,	 respectively	 the	
inhibition	 of	 aromatase	 activity.	 Aromatase	 or	
estrogen	synthetase	is	an	enzyme	responsible	for	
estrogen	 synthesis.	 A	 large	 proportion	 of	 breast	
cancer	expresses	their	own	aromatase;	therefore,	
the	cell	proliferation	is	enhanced	by	an	autocrine	
stimulating	 mechanism.	 E alatus	 was	 highly	
effective	 in	 inhibiting	the	 intracellular	aromatase	
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Tab. 2. The	 effect	 of E. europaeus alcoholic	 extract	 on	 the	 cytology	 of	 the	
peritoneal		 fluid	(mean	±	S.E.M.)	(%)
Group EAC	cells	 N E L	 M I 65.00±8.44 23.25±06.26 0.00±0.00 11.75±03.57 0.00±0.00II 28.50±9.58 45.50±011.44 0.33±0.21 25.50±14.18 0.17±0.17III 56.25±5.86 35.50±04.21 0.00±0.00 08.25±01.79 0.00±0.00
S.E.M	=	Standard	Error	of	the	Mean	(8	animals	/	group)
EAC	cells	–	Ehrlich	ascitic	carcinoma	cells,	N	–	Neutrophils,	E	–	Eosinophils,	B	–	Basophiles,	L	–	Lymphocytes,	M	–	
Monocytes
Fig. 2. Effects	of	Euonymus europaeus	extract	on	ascitic	fluid	accumulation	(ml)	(A)	and	viable	Ehrlich	tumor	cells	
concentration	(B).	
(*	=	p>0.05:	**	=	p>0.01;	as	compared	to	EAC	group).	(mean	±	SEM)	(8	animals	/	group)
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in	 myometrial	 and	 leiomyomal	 cells,	 in	 dose-
dependent	 manner,	 consequently	 inhibiting	 the	
estrogen	synthesis	in	tumor	cells	(Lee	et al.	2004).
The	toxicity	of	EE	on	mice	was	evaluated	in	a	
previous	study	(Sevastre	et al.	2014).	All	the	mice	
subjected	to	toxicity	test	remained	alive	until	the	
end	 of	 the	 study;	 therefore,	 LD	 50	 could	 not	 be	
established.	 Gross	 necropsy	 and	 histopathology	
did	not	reveal	abnormalities	in	any	of	the	organs.	
Serum	 biochemistry	 and	 complete	 blood	 count	
showed	 normal	 values,	 therefore	 we	 concluded	
that	 findings	 suggest	 that	 the	 EE	 extract	 is	 safe	
even	at	very	high	dose	(Sevastre	et al.	2014).	
The	 EAC	 is	 a	 transplantable	 tumor	 of	
epithelial	 origin	 descended	 from	 a	 murine	
mammary	 gland	 adenocarcinoma.	 Not	 only	 it	
provides	 an	 appropriate	 model	 to	 assess	 the	
antiproliferative	 effects	 of	 various	 compounds,	
but	it	is	also	suitable	to	investigate	the	side	effects	
of	 tumor	 growth	 and	 the	 interaction	 between	
tumor	cells	and	the	 immune	system.	The	Ehrlich	
tumor	cells	development	in	the	abdominal	cavity	
results	 in	 accumulating	 of	 abundant	 exudate,	
rich	in	tumor	cells.	Mediators	produced	by	tumor	
cells	 are	 responsible	 for	 the	 increased	 vascular	
permeability,	 which	 leads	 to	 the	 extensive	
red	 blood	 cells	 leakage	 into	 abdominal	 cavity,	
resulting	 in	 anemia.	 This	 is	 widely	 accepted	 as	
malignant	 consequence	 of	 the	 EAC.	 Hemorrhage	
is	 secondary	 to	 extensive	 extravasations	 of	 red	
blood	 cells	 in	 peritoneal	 cavity,	 which	 leads	 to	
degradation	 of	 peritoneal	 capillaries	 (Mayer,	
1966).	 In	 our	 current	 findings,	 supported	 by	
previous	 studies	 performed	 on	 Ehrlich	 ascitic	
tumor	cells,	decreased	numbers	of	 inflammatory	
cells	 were	 present,	 even	 in	 highly	 hemorrhagic	
samples,	 but	 they	 can	 increase	 significantly	 in	
response	to	therapy.	Furthermore,	we	proved	that	
the	 concentration	 of	 inflammatory	 cells	 in	 the	
ascitic	fluid	is	negative	correlated	to	the	quantity	
of	 ascitic	 fluid	 and	 tumor	 cell	 concentration	
(Sarpataki	 et al.,	 2011).	 The	 inflammatory	 cells	
found	 in	 the	 ascitic	 fluid	 seem	 to	 provide	 some	
protective	effect,	but	the	blood	leukocytes	had	no	
influence	on	tumor	cells	development.	WBCs	reach	
elevated	concentrations	in	response	to	tumor	cell	
proliferation,	more	 likely	because	of	having	been	
stimulated	 by	 inflammatory	 cytokines	 produced	
by	 tumor	 cells.	However,	 circulating	white	 blood	
cells	seem	to	provide	little	protection,	because	they	
are	in	negative	correlation	with	the	inflammatory	
cell	population	in	ascitic	fluid.	
The	current	data,	 as	described	above,	 shows	
that	 EE	 extract	 significantly	 (p<0.05)	 reduced	
ascitic	fluid	accumulation	and	inhibited	tumor	cell	
proliferation	 in	 a	 dose-dependent	 manner.	 The	
anticancer	mechanism	is	likely	to	be	provided	by	
more	than	one	mechanism.	The	EE	extract	clearly	
reduced	 the	 intensity	 of	 ascitic	 hemorrhage,	 but	
whether	 it	was	a	specific	protective	effect	on	the	
vascular	walls	 or	 a	 simple	 side	 effect	 of	 reduced	
proliferation,	 remains	 to	 be	 established.	 The	
Anticancer	Activity	of	Euonymus europaeus Fruit	Extract	on	Transplantable	Mouse	Tumor	Model
Fig. 3. Effects	of	Euonymus europaeus	50	mg/kg	on	survival	curves	of	EAC	bearing	
mice.	(mean	±	SEM)	(p<0.05)	(8	animals	/	group)
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antiproliferative	 effect	 of	 EE	 was	 undoubtedly	
proven,	by	reduced	body	weight	gain,	by	decreased	
ascitic	 fluid	 volume	 and	 decreased	 viable	 tumor	
cells.	Furthermore,	the	survival	experiment	proved	
that	EE	therapy	was	able	to	improve	the	survival	
rate	in	a	significant	manner.	The	antiproliferative	
effect	 may	 be	 due	 to	 the	 induction	 of	 apoptosis	
or	cell	cycle	arrest,	but	the	enhancement	of	 local	
immune	 activity	 cannot	 be	 excluded	 either.	 As	
support	to	the	last	hypothesis,	there	is	an	elevated	
number	of	neutrophils	and	lymphocytes	found	in	
the	ascitic	fluid	as	a	response	to	therapy.		
In	 the	 present	 study,	we	 proved	 that	 the	 EE	
alcoholic	 extract	 inhibits	 the	 development	 of	
Ehrlich	tumor	cells	on	mice	model.	The	inhibition	
was	 positively	 correlated	 with	 the	 amplitude	 of	
the	local	inflammatory	response	in	the	peritoneal	
fluid	and	negatively	correlated	with	the	systemic	
inflammatory	 response,	 which	 suggest	 that	 the	
enhancement	of	cell-mediated	immunity	might	be	
part	of	the	tumoricidal	properties	of	EE.		
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